Moderna's $1 Billion Revenue Forecast Cut Sends Stock Plummeting Over 20%
1. Moderna reduced its 2025 revenue forecast by $1 billion. 2. Projected revenue is now $1.5 to $2.5 billion this year. 3. Shares fell over 20% to $33.44 on the announcement. 4. MRNA has lost two-thirds of its value since last year. 5. Company plans $1 billion expense cuts in 2025.